GENE ONLINE|News &
Opinion
Blog

Regeneron
Funding HHSCOVID-19
U.S. Government Awards $1.4 Billion to Advance COVID Therapies and Vaccines
2023-08-29
Trials & Approvals Hypercholesterolemia
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Partnerships Regeneron
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Trials & Approvals Cervical Cancer
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
Dupixent
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
Trials & Approvals Sanofi
Sanofi and Regeneron Post Positive Results from Child Throat Disease Trial
2022-07-15
LATEST
Biotech Sector Updates: Reports Cover Research Advances and Industry Events
2025-05-14
GSK Adds Efimosfermin to Hepatology Portfolio, Citing Novel Mechanism of Action for Liver Disease Treatment
2025-05-14
New Generic Drug Impacts Oncology and Community Pharmacists.
2025-05-14
Novo Nordisk and Septerna Partner to Develop Oral Obesity Medications
2025-05-14
Ixchiq Vaccine Adverse Event Investigations Focus on Elderly Recipients
2025-05-14
Liver Disease Treatment Investment Resurges Amid Growing Unmet Needs
2025-05-14
Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top